نتائج البحث - "Sulur, G."

1

Academic Journal

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.

المؤلفون: Chesney, J, Lewis, KD, Kluger, H, Hamid, O, Whitman, E, Thomas, S, Wermke, M, Cusnir, M, Domingo-Musibay, E, Phan, GQ, Kirkwood, JM, Hassel, JC, Orloff, M, Larkin, J, Weber, J, Furness, AJS, Khushalani, NI, Medina, T, Egger, ME, Graf Finckenstein, F, Jagasia, M, Hari, P, Sulur, G, Shi, W, Wu, X, Sarnaik, A

المساهمون: Furness, Andrew

مصطلحات موضوعية: Clinical Trials, Phase II as Topic, Immunotherapy, Adoptive, Lymphocytes, Tumor-Infiltrating, Melanoma, Humans, Immune Checkpoint Inhibitors, Skin Neoplasms

جغرافية الموضوع: England

وصف الملف: Print; application/pdf

Relation: ARTN e005755; jitc-2022-005755; Journal for ImmunoTherapy of Cancer, 2022, 10 (12), pp. e005755 -; https://repository.icr.ac.uk/handle/internal/5725

الاتاحة: https://repository.icr.ac.uk/handle/internal/5725
https://doi.org/10.1136/jitc-2022-005755

View record in BASE

Full Text Finder

2

Academic Journal

119O Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study

المؤلفون: Medina, T., Chesney, J.A., Whitman, E., Kluger, H., Thomas, S., Sarnaik, A., Kirkwood, J.M., Larkin, J., Weber, J.S., Hamid, O., Wermke, M., Finckenstein, F. Graf, Chou, J., Gastman, B., Sulur, G., Wu, X., Shi, W., Domingo-Musibay, E.

المصدر: Immuno-Oncology and Technology ; volume 20, page 100591 ; ISSN 2590-0188

الاتاحة: http://dx.doi.org/10.1016/j.iotech.2023.100591
https://api.elsevier.com/content/article/PII:S259001882300254X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S259001882300254X?httpAccept=text/plain

View record in BASE

3

Academic Journal

844P Efficacy and safety of lifileucel, an investigational autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma previously treated with anti-LAG3 antibody

المؤلفون: Larkin, J., Dalle, S., Sanmamed, M.F., Wilson, M., Hassel, J.C., Kluger, H., Orloff, M., Weber, J.S., Graf Finckenstein, F., Hari, P., Jagasia, M., Yin, H., Shi, W., Sulur, G., Wu, X., Gontcharova, V., Lewis, K.

المصدر: Annals of Oncology ; volume 33, page S935-S936 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2022.07.970
https://api.elsevier.com/content/article/PII:S0923753422028216?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753422028216?httpAccept=text/plain

View record in BASE

4

Academic Journal

1086MO Lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced mucosal melanoma after progression on immune checkpoint inhibitors (ICI): Results from the phase II C-144-01 study

المؤلفون: Grigoleit, G-U., Kluger, H., Thomas, S., Chesney, J.A., Domingo-Musibay, E., Sanmamed, M.F., Medina, T., Ziemer, M., Whitman, E., Graf Finckenstein, F., Chou, J., Wu, X., Sulur, G., Shi, W., Sarnaik, A.

المصدر: Annals of Oncology ; volume 34, page S654 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2023.09.2220
https://api.elsevier.com/content/article/PII:S0923753423030570?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753423030570?httpAccept=text/plain

View record in BASE

5

Academic Journal

LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT+abiraterone acetate and prednisone (AAP) or placebo (PBO)

المؤلفون: Matsubara, N., Chi, K.N., Ozguroglu, M., Rodriguez Antolin, A., Feyerabend, S., Fein, L., Alekseev, B.Y., Sulur, G., Protheroe, A., Li, S., Mundle, S.D., De Porre, P., Tran, N., Fazazi, K.

المصدر: Annals of Oncology ; volume 29, page viii273-viii274 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdy284.006
https://api.elsevier.com/content/article/PII:S0923753419493277?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419493277?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy284.006/26139228/mdy284.006.pdf

View record in BASE

6

Academic Journal

Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): Post Hoc Analysis Of EQ-5D-5L From The Latitude Study

المؤلفون: Metin, H, McQuarrie, K, Thilakarathne, P, Diels, J, Ito, T, Li, T, Sulur, G, Chi, KN, Fizazi, K

المصدر: Value in Health ; volume 21, page S38 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2018.04.317
https://api.elsevier.com/content/article/PII:S109830151830617X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S109830151830617X?httpAccept=text/plain

View record in BASE

7

Academic Journal

(2R)-4-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-methylpiperazin-1-ium chloride

المؤلفون: Anne Ertan, Parhalad Sharma, Dokka Nagaraju, K. Deepthi, Sulur G. Manjunatha

المصدر: Acta Crystallographica Section E, Vol 67, Iss 12, Pp o3386-o3387 (2011)

مصطلحات موضوعية: Crystallography, QD901-999

وصف الملف: electronic resource

Relation: http://scripts.iucr.org/cgi-bin/paper?S1600536811048306; https://doaj.org/toc/1600-5368

URL الوصول: https://doaj.org/article/fdbdff1da21640969dd5132517aed969

View record in DOAJ

Full Text Finder

8

Academic Journal

Data collection

المؤلفون: Anne Ertan, A Parhalad Sharma, B Dokka Nagaraju, K. Deepthi B, Sulur G. Manjunatha B, Chno Cl

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/1a/32/Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_19_67(Pt_12)_o3386-o3387.tar.gz

وصف الملف: application/zip

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.286.9802

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.286.9802

View record in BASE

9

Patent

One Spot Synthesis of Citalopram from 5-Cyanophthalide

View record in USPTO Patent Applications

10

Conference

Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)

المؤلفون: Woo, H., Fizaz, K., Sulur, G., Tran, N., Fein, L., Matsubara, N., Chi, K.

Relation: Bju International; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; https://hdl.handle.net/20.500.12831/6551; 123; 27; 28; WOS:000464354600047

الاتاحة: https://hdl.handle.net/20.500.12831/6551

View record in BASE

Full Text Finder

11

Patent

Process for the isolation of high purity crystalline citalopram base

View record in USPTO Patent Grants

12

Patent

Process for the preparation of risperidone

View record in USPTO Patent Applications

13

Patent

Process for the preparation of 5-substituted-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans

View record in USPTO Patent Applications

14

Patent

Process for the isolation of high purity crystalline citalopram base

View record in USPTO Patent Applications

15

Report

LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT plus abiraterone acetate and prednisone (AAP) or placebo (PBO)

المؤلفون: Tran, N., Ozguroglu, M., Sulur, G., Protheroe, A., Li, S., Mundle, S. D., Chi, K. N., Rodriguez Antolin, A., Feyerabend, S., Fein, L., Alekseev, B. Y., De Porre, P., Matsubara, N., Fazazi, K.

المساهمون: National Cancer Center - Japan ,, 154950

مصطلحات موضوعية: Klinik Tıp (MED), Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, ONKOLOJİ, Klinik Tıp

Relation: Matsubara N., Chi K. N. , Ozguroglu M., Rodriguez Antolin A., Feyerabend S., Fein L., Alekseev B. Y. , Sulur G., Protheroe A., Li S., et al., "LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT plus abiraterone acetate and prednisone (AAP) or placebo (PBO)", 43rd ESMO Congress (ESMO), Munich, Almanya, 19 - 23 Ekim 2018, cilt.29; av_b7e5e76c-8656-4c31-b7d5-969bd243e9ca; vv_1032021; http://hdl.handle.net/20.500.12627/122369; 29

الاتاحة: https://hdl.handle.net/20.500.12627/122369

View record in BASE

16

Report

Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)

المؤلفون: Mundle, S., Li, S., Luna, Y., Chi, K., Ozguroglu, M., Woo, H., Fizaz, K., Sulur, G., Tran, N., Fein, L., Matsubara, N., Rodriguez-Antolin, A., Alekseev, B., Ye, D., Feyerabend, S., Protheroe, A.

المساهمون: University Of Sydney ,, 155921

مصطلحات موضوعية: Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Nefroloji, ÜROLOJİ VE NEFROLOJİ, Tıp, Klinik Tıp (MED), Klinik Tıp

Relation: Woo H., Fizaz K., Sulur G., Tran N., Fein L., Matsubara N., Rodriguez-Antolin A., Alekseev B., Ozguroglu M., Ye D., et al., "Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)", Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane, Avustralya, 13 - 16 Nisan 2019, cilt.123, ss.27-28; vv_1032021; av_0a36b8bf-1d97-4a47-9742-01301f6e0d58; http://hdl.handle.net/20.500.12627/12622; 123

الاتاحة: https://hdl.handle.net/20.500.12627/12622

View record in BASE